Sanofi to Start Dengue Vaccine Registration in Endemic Countries in 2015
04 November 2014 - 6:21PM
Dow Jones News
By Inti Landauro
PARIS-- French pharmaceutical group Sanofi SA (SAN.FR) said it
plans to file for registration of its dengue vaccine in 2015 in
several countries where the disease is endemic after the
publication of results of the final clinical study in Latin
America.
The company said the vaccine's overall efficacy against any
symptomatic dengue disease was 60.8% in children and adolescents,
while analyses showed a 95.5% protection against severe dengue and
an 80.3% reduction in the risk of hospitalization during the
study.
Sanofi said the world's first dengue vaccine could be available
in the second half of 2015.
Dengue is a disease transmitted by mosquitoes that is endemic in
parts of Asia and Latin America and is expanding geographically.
About 550,000 people are hospitalized every year due to severe
dengue. The disease can develop in a hemorrhagic fever that can be
deadly. Sanofi says dengue is a threat for 2.5 billion people.
-Write to Inti Landauro at inti.landauro@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From Apr 2024 to May 2024
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From May 2023 to May 2024